Sectors

WAT
Waters Corporation
332.00
1 x 331.01
1 x 333.23
bid
ask
-
1.21
0.36%
10:12 AM
timesize
Ytd -12.59%
1y -5.57%
328.22
day range
333.91
275.05
52 week range
414.15
Open 328.21 Prev Close 333.21 Low 328.22 High 333.91 Mkt Cap 32.67B
Vol 72.21K Avg Vol 1.14M EPS 7.86 P/E 42.33 Forward P/E 21.50
Beta 1.14 Short Ratio 3.89 Inst. Own 71.84% Dividend N/A Div Yield N/A
Ex Div Date 11-26 Earning 07-29 50-d Avg 313.25 200-d Avg 336.94 1yr Est 397.32
Earning
Date For Estimate Reported Surprise surprise %
2026-05-05 2026-03 2.31 2.7 0.39 16.88%
2026-02-09 2025-12 4.5 4.53 0.03 0.67%
2025-11-04 2025-09 3.21 3.4 0.19 5.92%
2025-08-04 2025-06 2.93 2.95 0.02 0.68%
2025-05-06 2025-03 2.22 2.25 0.03 1.35%
2025-02-12 2024-12 4.02 4.1 0.08 1.99%
Upgrade / Downgrade
Date Firm Action From To
2026-05-14 Wells Fargo Upgrade Equal-Weight Equal-Weight
2026-05-07 Barclays Upgrade Overweight Overweight
2026-05-06 UBS Upgrade Neutral Neutral
2026-05-06 JP Morgan Upgrade Neutral Neutral
2026-05-06 TD Cowen Upgrade Hold Hold
2026-04-13 UBS Upgrade Neutral Neutral
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Insider Holder
Date Name Relation Quantity Description
2026-02-24 BATRA UDIT Chief Executive Officer 36.56K Stock Award(Grant)
2026-02-24 BENNETT JIANQING Officer 7.24K Stock Award(Grant)
2026-02-24 CARPIO ROBERT L III Officer 3.62K Stock Award(Grant)
2026-02-24 CHAUBAL AMOL Chief Financial Officer 8.51K Stock Award(Grant)
2026-03-05 FEARON RICHARD H Director 3.30K Purchase
2026-02-24 HUANG PEARL S. Director 3.28K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 8.54M 2.85B 8.70%
2026-03-30 Vanguard Capital Management LLC 6.38M 2.12B 6.50%
2026-03-30 Vanguard Portfolio Management LLC 4.75M 1.58B 4.84%
2025-12-30 Fundsmith LLP 3.56M 1.19B 3.62%
2025-12-30 State Street Corporation 2.68M 893.78M 2.73%
2025-12-30 Massachusetts Financial Services Co. 2.62M 874.32M 2.67%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.88M 624.81M 1.91%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 1.50M 500.11M 1.53%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 1.30M 431.65M 1.32%
2026-03-30 iShares Trust-iShares Core S&P 500 ETF 1.26M 419.87M 1.28%
2026-03-30 Fidelity Concord Street Trust-Fidelity 500 Index Fund 1.25M 417.23M 1.28%
2026-03-30 JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund 1.17M 389.76M 1.19%
Dividend
Dividend Date
0.16 1996-11-26
Split
Split Date
2 : 1 2000-08-28
2 : 1 1999-06-11